Public illness: How the community recommended complementary and alternative medicine for a prominent politician with cancer

Medical Journal of Australia

Volumn 183, Issue 11-12, 2005, Pages 576-579

  Lowenthal, Ray M ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; ASCORBIC ACID; CARICA PAPAYA EXTRACT; CHINESE DRUG; CHYMOTRYPSIN; DIMETHYLGLYCINE; GANODERMA LUCIDUM EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLYCOPROTEIN; GLYCYRRHIZA EXTRACT; INSULIN DERIVATIVE; IRINOTECAN; LAETRILE; LINSEED OIL; MOLASSES; ONION EXTRACT; OXYGEN; SILICON DIOXIDE; TRACE ELEMENT; TRANSFER FACTOR; TRYPSIN; UBIQUINONE; VITAMIN B GROUP; XANTHONE DERIVATIVE; YOGHURT;

ACCESS TO INFORMATION; ALTERNATIVE MEDICINE; ARTICLE; AUSTRALIA; BEVERAGE; CANCER PATIENT; CHINESE MEDICINE; COMMUNITY CARE; DIET SUPPLEMENTATION; DIET THERAPY; E-MAIL; EVIDENCE BASED MEDICINE; HEALTH PRACTITIONER; HUMAN; LABORATORY TEST; LUNG CANCER; MEDITATION; POLITICS; POSTAL MAIL; RISK BENEFIT ANALYSIS;

EID: 29444434779     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb00039.x     Document Type: Article

References (27)

1. MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002; 35: 166-173.
2. Lowenthal RM. Alternative cancer treatments [editorial]. Med J Aust 1996; 165: 536-537.
3. Ernst E, Cassileth B. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83: 777-782.
4. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aust 1996; 165: 545-548.
5. Miller M, Boyer M, Butow P, et al. The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer 1998; 6: 337-347.
6. Ellison NM, Byar DP, Newell GR. Special report on Laetrile: the NCI Laetrile review. Results of the National Cancer Institute's retrospective Laetrile analysis. N Engl J Med 1978; 299: 549-552.
7. Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301: 687-690.
8. Lowenthal RM. On eye of newt and bone of shark. The dangers of promoting alternative cancer treatments. Med J Aust 1994; 160: 323-324.
9. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000; 18: 2515-2521.
10. Munstedt K, Entezami A, Kullmer U. [Oncologic mistletoe therapy: physicians' use and estimation of efficiency]. [German]. Dtsch Med Wochenschr 2000; 125: 1222-1226.
11. Senate Community Affairs References Committee. The cancer journey: informing choice. Canberra: The Senate, 2005. Available at: http://www.aph.gov.au/Senate/committee/clac_ctte/cancer/report/index.htm (accessed Oct 2005).
12. American Cancer Society's guide to complementary and alternative cancer methods. Atlanta: American Cancer Society, 2000.
13. Moertel CG, Fleming TR, Rubin J. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982; 306: 201-206.
14. Braico KT, Humbert JR, Terplan KL, Lehotay JM. Laetrile intoxication. Report of a fatal case. N Engl J Med 1979; 300: 238-240.
15. Cassileth BR. The alternative medicine handbook: the complete reference guide to alternative and complementary therapies. New York: WW Norton, 1998.
16. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA 1992; 268: 3224-3227.
17. Loprinzi CL, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer 2005; 104: 176-182.
18. See DM, Cimoch P, Chou S, et al. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 280-287.
19. Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000; 62: 613-622.
20. Targ EF, Levine EG. The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial. Gen Hosp Psychiatry 2002; 24: 238-248.
21. Ghafar MA, Golliday E, Bingham J, et al. Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report. J Altern Complement Med 2002; 8: 493-497.
22. Stanley G, Harvey K, Slivova V, et al. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 2005; 330: 46-52.
23. Moongkarndi P, Kosem N, Kaslungka S, et al. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol 2004; 90: 161-166.
24. Abbott T. Review of microwave cancer therapy. Media release ABB118/05. 29 September 2005. Available at: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/ health-mediarel-yr2005-ta-abb118.htm (accessed Oct 2005).
25. Ernst E. A primer of complementary and alternative medicine commonly used by cancer patients. Med J Aust 2001; 174: 88-92.
26. Mathijssen RH, Verweij J, de Bruijn P, et al. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94: 1247-1249.
27. Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer 2004; 12: 797-804.